Nutritional Therapeutics
This article was originally published in The Tan Sheet
Executive Summary
Hauppauge, N.Y.-based manufacturer funding two clinical trials studying the effects of its Propax dietary supplement on chemotherapy-related, quality-of-life factors in cancer patients. NTI says Propax provides "premium nutritional support" with vitamins, minerals, amino acids, essential fatty acids, antioxidants and probiotics. Enrollment of 60 patients in a double-blind, placebo-controlled crossover study at Harbor-UCLA Medical Center is under way, and will run two-and-a-half months. An open label, non-crossover study following 40 patients over a 60-day period is slated to commence at the East Texas Medical Center Healthcare System this fall. The American Nutraceutical Association is coordinating the studies